Latest News

19

June 2018

iX Biopharma Ltd. is pleased to announce the approval by Therapeutic Goods Administration, the regulatory authority in Australia, for WAFESIL (sublingual sildenafil wafer)...

Read On

10

May 2018

iX Biopharma Ltd. has reported results for the third financial quarter ended 31 March 2018 (unaudited).

Read On

Our Sublingual Technology

Sublingual wafer administration offers the convenience of use over oral delivery, circumventing the drug breakdown in liver or gastrointestinal tract. The technology also provides rapid absorption, achieving maximum desirable therapeutic effect in a non-invasive manner.

Read On

Contact us

iX Biopharma Ltd

1 Kim Seng Promenade
#14-01 Great World City East Tower
Singapore 237994
T: +65 6235 2270
F: +65 6235 2170
E: info@ixbiopharma.com